Cargando…

The contribution of benzene to smoking-induced leukemia.

Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Korte, J E, Hertz-Picciotto, I, Schulz, M R, Ball, L M, Duell, E J
Formato: Texto
Lenguaje:English
Publicado: 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1638019/
https://www.ncbi.nlm.nih.gov/pubmed/10753092
_version_ 1782130957610909696
author Korte, J E
Hertz-Picciotto, I
Schulz, M R
Ball, L M
Duell, E J
author_facet Korte, J E
Hertz-Picciotto, I
Schulz, M R
Ball, L M
Duell, E J
author_sort Korte, J E
collection PubMed
description Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induced total leukemia deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced AML deaths (95% UCL, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions--all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions.
format Text
id pubmed-1638019
institution National Center for Biotechnology Information
language English
publishDate 2000
record_format MEDLINE/PubMed
spelling pubmed-16380192006-11-17 The contribution of benzene to smoking-induced leukemia. Korte, J E Hertz-Picciotto, I Schulz, M R Ball, L M Duell, E J Environ Health Perspect Research Article Cigarette smoking is associated with an increased risk of leukemia; benzene, an established leukemogen, is present in cigarette smoke. By combining epidemiologic data on the health effects of smoking with risk assessment techniques for low-dose extrapolation, we assessed the proportion of smoking-induced total leukemia and acute myeloid leukemia (AML) attributable to the benzene in cigarette smoke. We fit both linear and quadratic models to data from two benzene-exposed occupational cohorts to estimate the leukemogenic potency of benzene. Using multiple-decrement life tables, we calculated lifetime risks of total leukemia and AML deaths for never, light, and heavy smokers. We repeated these calculations, removing the effect of benzene in cigarettes based on the estimated potencies. From these life tables we determined smoking-attributable risks and benzene-attributable risks. The ratio of the latter to the former constitutes the proportion of smoking-induced cases attributable to benzene. Based on linear potency models, the benzene in cigarette smoke contributed from 8 to 48% of smoking-induced total leukemia deaths [95% upper confidence limit (UCL), 20-66%], and from 12 to 58% of smoking-induced AML deaths (95% UCL, 19-121%). The inclusion of a quadratic term yielded results that were comparable; however, potency models with only quadratic terms resulted in much lower attributable fractions--all < 1%. Thus, benzene is estimated to be responsible for approximately one-tenth to one-half of smoking-induced total leukemia mortality and up to three-fifths of smoking-related AML mortality. In contrast to theoretical arguments that linear models substantially overestimate low-dose risk, linear extrapolations from empirical data over a dose range of 10- to 100-fold resulted in plausible predictions. 2000-04 /pmc/articles/PMC1638019/ /pubmed/10753092 Text en
spellingShingle Research Article
Korte, J E
Hertz-Picciotto, I
Schulz, M R
Ball, L M
Duell, E J
The contribution of benzene to smoking-induced leukemia.
title The contribution of benzene to smoking-induced leukemia.
title_full The contribution of benzene to smoking-induced leukemia.
title_fullStr The contribution of benzene to smoking-induced leukemia.
title_full_unstemmed The contribution of benzene to smoking-induced leukemia.
title_short The contribution of benzene to smoking-induced leukemia.
title_sort contribution of benzene to smoking-induced leukemia.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1638019/
https://www.ncbi.nlm.nih.gov/pubmed/10753092
work_keys_str_mv AT korteje thecontributionofbenzenetosmokinginducedleukemia
AT hertzpicciottoi thecontributionofbenzenetosmokinginducedleukemia
AT schulzmr thecontributionofbenzenetosmokinginducedleukemia
AT balllm thecontributionofbenzenetosmokinginducedleukemia
AT duellej thecontributionofbenzenetosmokinginducedleukemia
AT korteje contributionofbenzenetosmokinginducedleukemia
AT hertzpicciottoi contributionofbenzenetosmokinginducedleukemia
AT schulzmr contributionofbenzenetosmokinginducedleukemia
AT balllm contributionofbenzenetosmokinginducedleukemia
AT duellej contributionofbenzenetosmokinginducedleukemia